The Affordability Gap in Healthcare-A Global Reality
The shifting climates, lifestyles, and genetics have increased vulnerabilities, not only the scarcity of resources, but also an increase in diseases and health disorders, both infectious and chronic.
The rising disease burdens have made healthcare an indispensable need of the time.
Despite scientific advancements, millions die unable to access expensive treatments.
Many diseases demand lifelong medication, like a kidney transplant, people leave the therapy and the medicines, due to the high cost.
Cancer treatment takes away lifelong savings.
Getting ill is not confined to health degradation, but it’s an economic catastrophe. The lifelong treatments and over-expensive medical care leave families vulnerable to debts and economic crisis.
The Critical Need for Affordable Medicine
Healthcare is not a luxury, it’s a need for survival.
Affordable healthcare builds global equity, improves human capital and drive economic growth.
It leads to early interventions and proper treatment adherence, increasing the survivability rates.
Why are Medicines Expensive?
Medicines are developed after a stringent process of molecular development, innovation, research, clinical trials, and regulatory clearances, which include extensive costs.
The manufacturing companies are given rights to patent these drug molecules for years and sell them at high prices to recoup their investment.
What are Affordable Alternatives?
After the period when the patent expires, the pharmaceutical companies are free to develop similar drug molecules, with the same efficacy and safety.
These are available at low prices because they are bio equivalent to already developed drug molecules.
They do not undergo an extensive research process or early clinical trials.
They undergo the post-market surveillance and similar quality and safety assurances as the patented medicines.
Affordable Medicine Manufacturer
Aprazer Healthcare, redefining healthcare, bridges the affordability gap through its innovative healthcare solutions available at cost-effective prices.
Aprazer manufactures a diverse range of life-saving medicines in various therapeutic segments.
- • Anticancer Medicines
- • Hepatology Medicines – Hepatitis B medicines, Hepatitis C medicines
- • Gastroenterology Medicines
- • Nephrology Medicines
- • Erectile Dysfunction Medicines
- • Critical Care Medicines
- • Focus Therapy Medicines
- • HIV medicines
- • Rheumatology Medicines
Affordable Medicine Exporter and Supplier Worldwide
Committed to global health equity, Aprazer extends beyond barriers, making the essential medicines accessible across the globe.
Aprazer marks a remarkable global presence, extending its reach to emerging markets and economically weaker markets to build a sustainable healthcare ecosystem, leaving no one behind in access to essential medical needs.
Aprazer is present extensively in 50+ countries.
Africa, South America, South-East Asia, and CIS countries.
Championing Affordability, Aprazer Healthcare delivers hope, survival, and second chances to lives.
